These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7240439)
21. The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment. Tammara B; Trang JM; Kitani M; Miyamoto G; Bramer SL J Clin Pharmacol; 2002 Dec; 42(12):1318-25. PubMed ID: 12463726 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and metabolism of lidocaine in patients with renal failure. Collinsworth KA; Strong JM; Atkinson AJ; Winkle RA; Perlroth F; Harrison DC Clin Pharmacol Ther; 1975 Jul; 18(1):59-64. PubMed ID: 1149363 [TBL] [Abstract][Full Text] [Related]
23. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Gaillot J; Le Roux Y; Houghton GW; Dreyfus JF Sleep; 1987; 10 Suppl 1():7-21. PubMed ID: 3438645 [TBL] [Abstract][Full Text] [Related]
29. Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Bax ND; Tucker GT; Woods HF Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tocainide in patients with severe renal failure. Braun J; Sörgel F; Engelmaier F; Gluth WP; Gessler U Eur J Clin Pharmacol; 1985; 28(6):665-70. PubMed ID: 3933983 [TBL] [Abstract][Full Text] [Related]
31. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables. Fredrick DS; Boersma RB Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion. Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965 [TBL] [Abstract][Full Text] [Related]
34. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Säwe J Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045 [TBL] [Abstract][Full Text] [Related]
35. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Drayer DE; Lorenzo B; Werns S; Reidenberg MM Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics in patients with cardiac failure. Benowitz NL; Meister W Clin Pharmacokinet; 1976; 1(6):389-405. PubMed ID: 799548 [TBL] [Abstract][Full Text] [Related]
37. Altered prazosin pharmacokinetics in congestive heart failure. Baughman RA; Arnold S; Benet LZ; Lin ET; Chatterjee K; Williams RL Eur J Clin Pharmacol; 1980 Jun; 17(6):425-8. PubMed ID: 7398734 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of combined intraperitoneal and incisional lidocaine in the dog following ovariohysterectomy. Wilson DV; Barnes KS; Hauptman JG J Vet Pharmacol Ther; 2004 Apr; 27(2):105-9. PubMed ID: 15096108 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206 [TBL] [Abstract][Full Text] [Related]
40. Effect of mechanical ventilation on hepatic drug pharmacokinetics. Richard C; Berdeaux A; Delion F; Riou B; Rimailho A; Giudicelli JF; Auzépy P Chest; 1986 Dec; 90(6):837-41. PubMed ID: 3780330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]